{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Ophthalmologic+evaluation&page=2", "query": { "intervention": "Ophthalmologic evaluation", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Ophthalmologic+evaluation&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-15T20:42:05.389Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00198484", "title": "Evaluation of Vitrase as a Spreading Agent", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pain" ], "interventions": [ { "name": "Vitrase", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bausch & Lomb Incorporated", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 108, "start_date": "2004-10", "completion_date": "2005-02", "has_results": false, "last_update_posted_date": "2013-03-14", "last_synced_at": "2026-09-15T20:42:05.389Z", "location_count": 18, "location_summary": "Newport Beach, California • Sacramento, California • Littleton, Colorado + 15 more", "locations": [ { "city": "Newport Beach", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Littleton", "state": "Colorado" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Fort Oglethorpe", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00198484" }, { "nct_id": "NCT07566975", "title": "Real-World Assessment of VEVYE® for Short-Term Symptom and Sign Improvement of Dry Eye Disease in a Neuro-Ophthalmology Clinic: A 6-Month Prospective Observational Study", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Dry Eye" ], "interventions": [ { "name": "Cyclosporine ophthalmic solution 0.1%", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Neuro-Ophthalmology of Texas", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50, "start_date": "2026-03-31", "completion_date": "2026-11-30", "has_results": false, "last_update_posted_date": "2026-05-05", "last_synced_at": "2026-09-15T20:42:05.389Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07566975" }, { "nct_id": "NCT03862222", "title": "Atlas of Retinal Imaging in Alzheimer's Study", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Alzheimer Disease", "Mild Cognitive Impairment", "Mild Dementia", "Aging", "Cognitive Change" ], "interventions": [ { "name": "Retinal Imaging", "type": "OTHER" }, { "name": "Pupillometry", "type": "OTHER" }, { "name": "Contrast Sensitivity", "type": "OTHER" }, { "name": "Neuropsychological Evaluation", "type": "DIAGNOSTIC_TEST" }, { "name": "APOE genotyping", "type": "GENETIC" }, { "name": "blood draw", "type": "OTHER" }, { "name": "Gait Assessment", "type": "OTHER" }, { "name": "Actigraphy", "type": "OTHER" } ], "intervention_types": [ "OTHER", "DIAGNOSTIC_TEST", "GENETIC" ], "sponsor": "University of Rhode Island", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "55 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "55 Years to 80 Years" }, "enrollment_count": 165, "start_date": "2019-12-16", "completion_date": "2025-05-31", "has_results": false, "last_update_posted_date": "2025-06-05", "last_synced_at": "2026-09-15T20:42:05.389Z", "location_count": 4, "location_summary": "Clearwater, Florida • St. Petersburg, Florida • Kingston, Rhode Island + 1 more", "locations": [ { "city": "Clearwater", "state": "Florida" }, { "city": "St. Petersburg", "state": "Florida" }, { "city": "Kingston", "state": "Rhode Island" }, { "city": "Providence", "state": "Rhode Island" } ], "official_url": "https://clinicaltrials.gov/study/NCT03862222" }, { "nct_id": "NCT00714363", "title": "Comparison of LASIK and SBK", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Myopia" ], "interventions": [ { "name": "LASIK", "type": "PROCEDURE" }, { "name": "SBK", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "University of Utah", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "21 Years to 80 Years" }, "enrollment_count": 40, "start_date": "2007-10", "completion_date": "2010-01", "has_results": false, "last_update_posted_date": "2010-10-19", "last_synced_at": "2026-09-15T20:42:05.389Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT00714363" }, { "nct_id": "NCT06164587", "title": "Evaluation of Kamuvudine-8 in Subjects With Geographic Atrophy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Geographic Atrophy", "Age-Related Macular Degeneration" ], "interventions": [ { "name": "K8", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Inflammasome Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "50 Years to 99 Years" }, "enrollment_count": 30, "start_date": "2024-04-18", "completion_date": "2026-05-15", "has_results": false, "last_update_posted_date": "2026-07-20", "last_synced_at": "2026-09-15T20:42:05.389Z", "location_count": 9, "location_summary": "Loma Linda, California • Lexington, Kentucky • Portland, Maine + 6 more", "locations": [ { "city": "Loma Linda", "state": "California" }, { "city": "Lexington", "state": "Kentucky" }, { "city": "Portland", "state": "Maine" }, { "city": "Eugene", "state": "Oregon" }, { "city": "Hilton Head", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT06164587" }, { "nct_id": "NCT00761826", "title": "Study of the MEL 80 Excimer Laser Using LASIK in the Treatment of Mixed Astigmatism", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Mixed Astigmatism" ], "interventions": [ { "name": "MEL 80 Mixed Astigmatism Treatment", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Carl Zeiss Meditec, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 126, "start_date": "2007-01", "completion_date": "2009-12", "has_results": false, "last_update_posted_date": "2018-07-19", "last_synced_at": "2026-09-15T20:42:05.389Z", "location_count": 5, "location_summary": "San Diego, California • Greenwood Village, Colorado • Kansas City, Missouri + 2 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Greenwood Village", "state": "Colorado" }, { "city": "Kansas City", "state": "Missouri" }, { "city": "Eugene", "state": "Oregon" }, { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT00761826" }, { "nct_id": "NCT07127757", "title": "Clinical Evaluation of WaveLight Plus LASIK", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Myopia", "Astigmatism" ], "interventions": [ { "name": "Wavelight Plus LASIK", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Laser Defined Vision", "sponsor_class": "OTHER", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50, "start_date": "2025-08-28", "completion_date": "2026-09-01", "has_results": false, "last_update_posted_date": "2025-10-02", "last_synced_at": "2026-09-15T20:42:05.389Z", "location_count": 1, "location_summary": "Greensboro, North Carolina", "locations": [ { "city": "Greensboro", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT07127757" }, { "nct_id": "NCT05186298", "title": "Prospective Evaluation and Comparison of Bilateral Synergy Implants and Bilateral PanOptix Implants", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cataract" ], "interventions": [ { "name": "AcrySof® IQ PanOptix®", "type": "DEVICE" }, { "name": "Synergy®", "type": "DEVICE" }, { "name": "Cataract Surgery", "type": "PROCEDURE" } ], "intervention_types": [ "DEVICE", "PROCEDURE" ], "sponsor": "Alterman, Modi, & Wolter Ophthalmic Physicians & Surgeons", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "22 Years", "maximum_age": null, "sex": "ALL", "summary": "22 Years and older" }, "enrollment_count": 320, "start_date": "2021-11-02", "completion_date": "2022-05", "has_results": false, "last_update_posted_date": "2022-01-11", "last_synced_at": "2026-09-15T20:42:05.389Z", "location_count": 5, "location_summary": "Panama City, Florida • Poughkeepsie, New York • Kingston, Pennsylvania + 2 more", "locations": [ { "city": "Panama City", "state": "Florida" }, { "city": "Poughkeepsie", "state": "New York" }, { "city": "Kingston", "state": "Pennsylvania" }, { "city": "Nacogdoches", "state": "Texas" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT05186298" }, { "nct_id": "NCT06700460", "title": "Measuring Outcomes of LASIK and EVO-ICL in Matched Populations", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Myopia" ], "interventions": [ { "name": "Laser-assisted in Situ Keratomileusis", "type": "DEVICE" }, { "name": "Implantable Collamer Lens placement", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Vance Thompson Vision", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "21 Years to 45 Years" }, "enrollment_count": 54, "start_date": "2024-11-27", "completion_date": "2025-11-13", "has_results": false, "last_update_posted_date": "2026-07-17", "last_synced_at": "2026-09-15T20:42:05.389Z", "location_count": 5, "location_summary": "Omaha, Nebraska • Cleveland, Ohio • Mt. Pleasant, South Carolina + 2 more", "locations": [ { "city": "Omaha", "state": "Nebraska" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Mt. Pleasant", "state": "South Carolina" }, { "city": "Sioux Falls", "state": "South Dakota" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06700460" }, { "nct_id": "NCT03952637", "title": "A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Lysosomal Diseases", "Gangliosidosis", "GM1" ], "interventions": [ { "name": "AAV9-GLB1", "type": "BIOLOGICAL" }, { "name": "Abdominal ultrasound", "type": "PROCEDURE" }, { "name": "Rituximab", "type": "DRUG" }, { "name": "Sirolimus", "type": "DRUG" }, { "name": "Methylprednisolone", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Audiology assessment with ABR", "type": "DIAGNOSTIC_TEST" }, { "name": "Bone density scan (DEXA)", "type": "DIAGNOSTIC_TEST" }, { "name": "Electrocardiogram (EKG)", "type": "DIAGNOSTIC_TEST" }, { "name": "Echocardiogram", "type": "DIAGNOSTIC_TEST" }, { "name": "Electroencephalogram (EEG) awake and extended overnight", "type": "OTHER" }, { "name": "Laboratory tests", "type": "DIAGNOSTIC_TEST" }, { "name": "Lumbar puncture", "type": "PROCEDURE" }, { "name": "Brain MRI/MRS/fMRI", "type": "PROCEDURE" }, { "name": "Neurocognitive testing", "type": "BEHAVIORAL" }, { "name": "Neurology exam", "type": "OTHER" }, { "name": "PICC or other Central line placement", "type": "BEHAVIORAL" }, { "name": "Skeletal survey", "type": "PROCEDURE" }, { "name": "Skin biopsy", "type": "PROCEDURE" }, { "name": "Speech and modified barium swallow study", "type": "PROCEDURE" }, { "name": "Ophthalmology exam", "type": "PROCEDURE" } ], "intervention_types": [ "BIOLOGICAL", "PROCEDURE", "DRUG", "DIAGNOSTIC_TEST", "OTHER", "BEHAVIORAL" ], "sponsor": "National Human Genome Research Institute (NHGRI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": "12 Years", "sex": "ALL", "summary": "6 Months to 12 Years" }, "enrollment_count": 54, "start_date": "2019-08-19", "completion_date": "2030-01-01", "has_results": false, "last_update_posted_date": "2026-09-11", "last_synced_at": "2026-09-15T20:42:05.389Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03952637" } ] }